Obesity Treatment in Surat: Are Mounjaro Injections Right for You?

Obesity treatment in Surat is facing a Mounjaro rush. A Bhaskar English report says doctors' OPDs have doubled in Ahmedabad and Surat, with many young women wanting rapid weight loss before their weddings. This case study looks at who is asking for the injection, who actually qualifies, and what safe treatment involves.

What is this case study about?

This case study examines one trend that is changing obesity treatment in Surat: a medicine made for long-term obesity care is being requested for a short-term goal. The table sums it up.

The case	The rush for Mounjaro injections for rapid weight loss in Gujarat
Where	Ahmedabad and Surat
What was reported	Doctors' OPDs have doubled, according to Bhaskar English
Who is asking	Many young women who want to look fit before their wedding
The medicine	Mounjaro (tirzepatide), a once-weekly prescription injection
Approved use in India	Type 2 diabetes, and chronic weight management at a BMI of 30 or more, or 27 or more with a weight-related illness
The gap	A long-term obesity medicine is being requested for a short-term cosmetic goal
The lesson	Assessment first, prescription second

What did the report find in Ahmedabad and Surat?

The Bhaskar English report describes Gujaratis rushing to take Mounjaro injections for rapid weight loss. It says young women prefer the injection to look fit before their weddings, and that doctors' OPDs have doubled in Ahmedabad and Surat.

Gujarat is not alone. A Reuters report found the same pattern across India, where brides and some grooms were asking doctors for weight loss drugs before their wedding. One bride said she lost 10 kg on Mounjaro before a February wedding, and another lost 15 kg before hers.

One detail from that report matters most for this case study. Most of the brides who spoke to Reuters stopped the injections soon after the wedding.

Why are young women asking for Mounjaro before weddings?

The demand is driven by a deadline, not a diagnosis. Three pressures come together:

• Social pressure: brides told Reuters they felt expected to look a certain way on the day.
• Social media: before-and-after stories make a prescription medicine look like a beauty treatment.
• Packaging: some clinics in India have added weight loss injections to pre-wedding makeover packages.

The manufacturer has stated that Mounjaro is not approved for cosmetic weight loss, and it must not be used for it.

What is Mounjaro actually approved for?

Mounjaro is the brand name of tirzepatide, a once-weekly injection that reduces appetite and slows stomach emptying. In India it is approved by the drug regulator (CDSCO) for type 2 diabetes and for chronic weight management, always alongside diet and exercise.

For weight management it is meant for adults with a BMI of 30 or more, or 27 or more with at least one weight-related condition. BMI, or body mass index, is weight in kilograms divided by height in metres squared.

The timeline does not suit a deadline either. Treatment starts at 2.5 mg a week and the dose is raised in steps of at least four weeks. In the main clinical trial, adults with obesity lost on average about 15 to 21% of their body weight, but over 72 weeks (New England Journal of Medicine).

Who is asking for the injection? Three patient profiles

Three kinds of people ask for the same injection, and each needs a different answer. These are illustrative profiles based on the requests described in news reports. They are not real patients.

Profile 1: The bride with ten weeks to go

• The request: a 26-year-old with a BMI of 24 wants to lose 8 kg before her wedding in ten weeks.
• The assessment: she has no weight-related illness and her BMI is below 27, so she is outside the approved use. In ten weeks she would still be on a starting dose, when nausea and loose motions are most common.
• The advice: no injection. By Indian cut-offs a BMI of 24 is overweight, so she gets a dietitian-led plan with enough protein, strength training and a steady, realistic target.

Profile 2: The woman who does qualify

• The request: a 33-year-old with a BMI of 31, prediabetes and PCOS wants the injection before her wedding in five months.
• The assessment: she meets the criteria. Her weight is already affecting her health.
• The advice: medication can be considered after baseline blood tests, with the goal set for her health over the next year and not for the wedding date. Tirzepatide is not used in pregnancy and can make oral contraceptive pills less reliable around dose changes, so family planning is discussed before the first dose.

Profile 3: The man who started on a friend's advice

• The request: a 42-year-old with a BMI of 38, type 2 diabetes and sleep apnoea took the injection for three months without follow-up, stopped, and regained the weight.
• The assessment: he qualifies for medication, and at a BMI above 35 he also qualifies for a bariatric surgery evaluation.
• The advice: a full work-up, then a choice between supervised long-term medication and a procedure such as gastric sleeve surgery or mini gastric bypass.

Profile	BMI	Weight-related illness	Meets the criteria?	Advised route
1. Bride, wedding in ten weeks	24	None	No	Diet and strength training
2. Woman, wedding in five months	31	Prediabetes, PCOS	Yes	Supervised medication with a long-term plan
3. Man, stopped and regained	38	Type 2 diabetes, sleep apnoea	Yes	Medication or bariatric surgery after evaluation

What are the risks of rapid weight loss on a wedding deadline?

Rapid weight loss on a deadline carries more risk than the same loss achieved slowly. The main ones are:

• Gallstones: losing weight very quickly raises the chance of gallstones (NIDDK, US National Institutes of Health). Pain in the upper right abdomen after meals needs a check for gallbladder stones.
• Muscle loss: without enough protein and strength training, the body loses muscle along with fat.
• Stomach side effects: nausea, vomiting and loose motions are most common at the start and after each dose increase, which can fall on the wedding functions.
• Pregnancy: tirzepatide is not used during pregnancy or while trying to conceive.
• Weight regain: in a follow-up trial, people switched from tirzepatide to a placebo regained weight over the next year.
• Unsafe supply: pens bought without a prescription or from unverified sellers may be fake or badly stored.

What does this case study teach about obesity treatment in Surat?

The lesson is that the injection is neither a villain nor a shortcut. It is one tool in obesity treatment, and it works when it is matched to the right patient.

1. Obesity is a long-term medical condition, so its treatment cannot be planned around an event.
2. BMI and weight-related illness decide eligibility, not the wedding date.
3. Every prescription needs baseline tests, a dietitian and regular follow-up.
4. The plan for stopping should be agreed before starting.
5. At a higher BMI, endoscopic sleeve gastroplasty or bariatric surgery may give a more lasting result than medication alone.

How is obesity treatment in Surat planned at Wings Hospital?

At Wings Hospital in Adajan, obesity treatment starts with an assessment, not a prescription. In our practice in Surat we commonly see people who started an injection on a friend's advice, without baseline tests or a plan for what happens after stopping.

Dr. Vikram R. Lotwala and the dietitian review your BMI, blood reports and medical history, then advise the least invasive option likely to work, from diet and weight loss medication to endoscopic and surgical procedures.

Frequently Asked Questions

Why are young women in Gujarat taking Mounjaro before weddings?

A Bhaskar English report says many young women in Ahmedabad and Surat want the injection to look fit before their wedding. Reuters has reported the same pattern across India, driven by social pressure and social media. Doctors caution that Mounjaro is an obesity and diabetes medicine, not a pre-wedding treatment.

Can Mounjaro give rapid weight loss in two or three months?

Not reliably, and it is not designed to. Treatment starts at a low dose that is raised in steps of at least four weeks, so the first months are mostly dose building. In the main clinical trial, the average loss of about 15 to 21 percent took 72 weeks of supervised treatment.

Who is eligible for Mounjaro in India?

Mounjaro is approved in India for adults with type 2 diabetes, and for chronic weight management in adults with a BMI of 30 or more, or 27 or more with at least one weight-related condition. It is a prescription-only medicine and is not approved for cosmetic weight loss.

What happens after you stop Mounjaro?

Most people regain a large part of the lost weight after stopping, unless eating and activity habits have changed. In a follow-up trial, people switched from tirzepatide to a placebo regained weight over the next year, while those who continued kept their loss. Plan the exit with your doctor before starting.

What is the cost of Mounjaro injection in India?

When the prefilled pen was launched in India in 2025, the manufacturer listed a month of treatment at roughly Rs 14,000 to Rs 27,500, depending on the dose. Prices can change, so confirm the current rate with a registered pharmacy. Consultation and blood test charges are separate.

Thinking about a weight loss injection before your wedding?

Get assessed before you start. For obesity treatment in Surat with a plan that covers diet, medication and surgical options, book an appointment with Dr. Vikram R. Lotwala at Wings Hospital, Off L.P. Savani Road, Adajan, Surat 395009, or call +91 9824437573.

Medical disclaimer: This article is for general education and is not a substitute for professional diagnosis or treatment. The patient profiles are illustrative and do not describe real people. Do not start, stop or change any medicine on the basis of this page. Please consult Dr. Vikram R. Lotwala or another qualified specialist about your own case.